Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenqiao Huang

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
American Journal of Ophthalmology|January 1, 2025
Ophthalmology Journals' Guidelines on Generative Artificial Intelligence: A Comprehensive AnalysisWenqiao Huang, Yating Liang, Xianghui Wei, et al.
Medicine|September 27, 2024
The efficacious combined treatment of rhegmatogenous retinal detachment (PVR ≤ C2) with inferior breaks using 25-gauge pars plana vitrectomy and air tamponadeGuangjie Han, Wenqiao Huang, Limei He, et al.
Frontiers in Neurology|October 16, 2023
Association of aquaporin-4 antibody-seropositive optic neuritis with vision-related quality of life and depressionRuitong Song, Wenqiao Huang, Jun Yang, et al.
European Journal of Pharmacology|September 18, 2025
KN060-a humanized dual-domain antibody simultaneously targeting FXI-A2/A3 epitopes: Pioneering the anti-coagulation factor XI strategy for Aterial hypertension - Evidence from preclinical modelsXiaoyan Yu, Qian Li, Doudou Zhang, et al.
Diabetes, Obesity & Metabolism|April 20, 2026
A Phase 1, Randomised, Double-Blind, Placebo-Controlled Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of KN069 (a Dual GLP-1R Agonist and GIPR Antagonist) in Male Adults With Overweight or ObesityJinlian Xie, Jie Huang, Qian Wu, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
American Journal of Ophthalmology|January 1, 2025
Ophthalmology Journals' Guidelines on Generative Artificial Intelligence: A Comprehensive AnalysisWenqiao Huang, Yating Liang, Xianghui Wei, et al.
Medicine|September 27, 2024
The efficacious combined treatment of rhegmatogenous retinal detachment (PVR ≤ C2) with inferior breaks using 25-gauge pars plana vitrectomy and air tamponadeGuangjie Han, Wenqiao Huang, Limei He, et al.
Frontiers in Neurology|October 16, 2023
Association of aquaporin-4 antibody-seropositive optic neuritis with vision-related quality of life and depressionRuitong Song, Wenqiao Huang, Jun Yang, et al.
European Journal of Pharmacology|September 18, 2025
KN060-a humanized dual-domain antibody simultaneously targeting FXI-A2/A3 epitopes: Pioneering the anti-coagulation factor XI strategy for Aterial hypertension - Evidence from preclinical modelsXiaoyan Yu, Qian Li, Doudou Zhang, et al.
Diabetes, Obesity & Metabolism|April 20, 2026
A Phase 1, Randomised, Double-Blind, Placebo-Controlled Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of KN069 (a Dual GLP-1R Agonist and GIPR Antagonist) in Male Adults With Overweight or ObesityJinlian Xie, Jie Huang, Qian Wu, et al.
Pageof 1